Compare Cassava Sciences Inc (FLNA) vs MobilEye Global Inc (MBLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs MobilEye Global Inc — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while MobilEye Global Inc trades at $8.9 (market cap $7.54B). The key difference: MobilEye Global Inc is far larger — about 157.9× Cassava Sciences Inc's market cap, and MobilEye Global Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | MBLY | |
|---|---|---|
Market Cap | $47.75M | $7.54B |
Sector | Health | Technology |
52-Week High | $4.64 | $15.54 |
52-Week Low | $0.87 | $6.56 |
Enterprise Value | -$34.93M | $6.10B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About MobilEye Global Inc
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →
